87 related articles for article (PubMed ID: 21740828)
1. Treatment of glomerulonephritis associated with hepatitis C virus in patient with cirrhosis: only pegylated interferon and ribavirin.
Taş A; Koçak E; Akbal E; Köklü S
Chin Med J (Engl); 2011 May; 124(10):1600. PubMed ID: 21740828
[No Abstract] [Full Text] [Related]
2. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
3. Review article: predicting response in hepatitis C virus therapy.
Mihm U; Herrmann E; Sarrazin C; Zeuzem S
Aliment Pharmacol Ther; 2006 Apr; 23(8):1043-54. PubMed ID: 16611264
[TBL] [Abstract][Full Text] [Related]
4. [Should we treat cirrhosis in hepatitis C carriers with antiviral agents?].
Brenard R; Closon ML; Fevery J; Hautekeete M
Rev Med Brux; 1999 Feb; 20(1):A50. PubMed ID: 10091538
[No Abstract] [Full Text] [Related]
5. High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.
Bressler BL; Guindi M; Tomlinson G; Heathcote J
Hepatology; 2003 Sep; 38(3):639-44. PubMed ID: 12939590
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hepatitis C virus: the first decade.
Poynard T
Semin Liver Dis; 2004; 24 Suppl 2():19-24. PubMed ID: 15346242
[TBL] [Abstract][Full Text] [Related]
7. Effect of antiviral therapy on hepatitis C virus related glomerulopathy.
Abbas G; Hussain S; Shafi T
Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):775-80. PubMed ID: 18711294
[TBL] [Abstract][Full Text] [Related]
8. Current therapies for chronic hepatitis C.
Ferguson MC
Pharmacotherapy; 2011 Jan; 31(1):92-111. PubMed ID: 21182362
[TBL] [Abstract][Full Text] [Related]
9. Future studies of combination therapy for chronic hepatitis C: optimizing response rates for each hepatitis C population.
Main J
J Hepatol; 1995; 23 Suppl 2():32-5; discussion 35-6. PubMed ID: 8720292
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of chronic hepatitis C].
Rókusz L
Orv Hetil; 2004 Aug; 145(32):1649-53. PubMed ID: 15384863
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of interferon and ribavirin in treatment of hepatitis C.
Feld JJ; Hoofnagle JH
Nature; 2005 Aug; 436(7053):967-72. PubMed ID: 16107837
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin.
Vukotic R; Gramenzi A; Vitale G; Cursaro C; Serra C; Biselli M; Scuteri A; Andreone P; Bernardi M
Liver Int; 2008 Mar; 28(3):407-11. PubMed ID: 17900241
[TBL] [Abstract][Full Text] [Related]
13. Management of hepatitis C virus genotype 4.
Abdo AA; Lee SS
J Gastroenterol Hepatol; 2004 Nov; 19(11):1233-9. PubMed ID: 15482528
[TBL] [Abstract][Full Text] [Related]
14. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
15. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.
Di Bisceglie AM; Thompson J; Smith-Wilkaitis N; Brunt EM; Bacon BR
Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751
[TBL] [Abstract][Full Text] [Related]
16. [The course of hepatitis C infection after liver transplantation].
Ołdakowska-Jedynak U; Paczek L
Pol Merkur Lekarski; 2005 Aug; 19(110):220-4. PubMed ID: 16245439
[TBL] [Abstract][Full Text] [Related]
17. [Treatment and prevention of hepatitis C].
Poynard T; Ratziu V; Benhamou Y; Regimbeau C
Rev Prat; 2000 May; 50(10):1100-7. PubMed ID: 10905096
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study.
Bonny C; Fontaine H; Poynard T; Hézode C; Larrey D; Marcellin P; Bourlière M; Bronowicki JP; Merle P; Zarski JP; Sapey T; Guillemard C; Ughetto S; Henquell C; Nicolas C; Roche C; Randl K; Bommelaer G; Abergel A
Aliment Pharmacol Ther; 2006 Aug; 24(4):593-600. PubMed ID: 16907892
[TBL] [Abstract][Full Text] [Related]
19. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
Böcher WO; Schuchmann M; Link R; Hillenbrand H; Rahman F; Sprinzl M; Mudter J; Löhr HF; Galle PR
Liver Int; 2006 Apr; 26(3):319-25. PubMed ID: 16584394
[TBL] [Abstract][Full Text] [Related]
20. Is serum uric acid a predictive factor of response to IFN-treatment in patients with chronic hepatitis C infection?
Pellicano R; Puglisi G; Ciancio A; Balzola F; Saracco G; Ciccone G; Baldi I; Abate ML; Smedile A; Rizzetto M
J Med Virol; 2008 Apr; 80(4):628-31. PubMed ID: 18297716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
